Ferritin is an iron storage protein expressed in varying concentrations in mammalian cells. The deposition of ferric iron in the core of ferritin makes it an MRI contrast agent, and ferritin has recently been proposed as a gene expression reporter protein for MRI. To date, ferritin has been overexpressed in vivo, and has been coexpressed with transferrin receptor to increase iron loading in cells. However, ferritin has a relatively low T 2 relaxivity (R 2~1 mM -1 sec -1 ) at typical magnetic field strengths), and so requires high levels of expression to be detected. One way to modulate the transverse relaxivity of a superparamagnetic agent is to cause it to aggregate, thereby manipulating the magnetic field gradients through which water diffuses. In this work, it is demonstrated by computer simulation and in vitro, that aggregation of ferritin can alter relaxivity. The effects of aggregate size and intra-aggregate perturber spacing on R 2 are studied. Computer modeling indicates that the optimal spacing of the ferritin molecules in aggregate for increasing R 2 is 100-200 nm for a typical range of water diffusion rates. Chemical crosslinking of ferritin at 12 Å spacing led to a 70% increase in R 2 compared to un-crosslinked ferritin controls. To modulate ferritin aggregation in a potentially biologically relevant manner, ferritin was attached to actin and polymerized in vitro. The polymerization of ferritin-(f-) actin caused a 20% increase in R 2 compared to unpolymerized ferritin-(g-) actin. The R 2 value was increased by another 10% by spacing the ferritin farther apart on the actin filaments. The modulation of ferritin aggregation by binding to cytoskeletal elements may be a useful strategy to make a functional reporter gene for MRI.
Introduction
Magnetic resonance imaging (MRI) has emerged as an important technology for the noninvasive assessment of biological tissue, and has enabled the assessment of anatomical and physiological processes for research and clinical applications. Some advantages of MRI as an imaging modality are its lack of ionizing radiation, high spatial resolution, and flexibility in type of contrast mechanisms. MRI offers the advantage of whole-tissue penetration with high resolution (hundreds of microns in each dimension) in a reasonable period of time. MRI has also been used to obtain information about molecular events in vivo (1) (2) (3) (4) (5) (6) .
There has been some interest in developing reporter protein strategies to use MRI to image gene expression. The large impact of green fluorescent protein and luciferase for optical imaging of gene expression makes it attractive to have an MRI reporter protein that would enable high resolution imaging throughout an organ. A reporter gene is a DNA construct that enables cells to express a protein which changes the MRI signal. The expression of the protein can be linked to activity of a different promoter (7) . There have been a number of demonstrations of MR reporter proteins including creatine kinase and arginine kinase, transferrin receptor, and polyarginine peptides (7) . None of these strategies has found widespread use. Recently, ferritin has been proposed as an MRI reporter protein. The presence and overexpression of ferritin, an iron storage protein, has been detected in vitro and in vivo using MRI (8) (9) (10) (11) . However, wild-type ferritin is a poor MR contrast agent, with per-iron relaxivity approximately 10-100-fold lower than similarly sized synthetic iron oxide particles used for cell labeling (12) , and a low perferritin relaxivity due to the fact that ferritin usually fills to approximately one third to one half of its maximum iron capacity (13) . Nonetheless, there are some characteristics of ferritin which could potentially be improved upon.
Ferritin has a magnetic moment that interacts with a strong magnetic field to produce a perturbation that is detectable with magnetic resonance (14) (15) (16) (17) (18) (19) . The electron spins of the ferritin iron atoms are anti-ferromagnetically coupled, but the relatively small size of the core creates a cooperativity of spins and results in a superparamagnetic molecule. In MRI of samples containing suspensions of ferritin, transverse relaxation rates are increased with an increase in ferritin concentration. The longitudinal (R 1 ) and transverse (R 2 ) relaxivities of different ferritin types depend on the amount of Fe 3+ in the core, field strength, and temperature (18) . A goal of previous work has been to noninvasively quantify the amount of iron present in liver, spleen, and other organs based on ferritin relaxivity (21) (22) . These measurements are useful for studying tissue damage due to iron storage diseases. The relaxivity of ferritin is on the order of 1-10 mM -1 sec -1 at typical magnetic field strengths in the range of 1-10 T. While synthetic versions of "magnetoferritin" have been produced in vitro (23) (24) , it is not yet clear that the fundamental relaxivity of the native ferritin molecule can be increased in vivo.
Studies of the tissue distribution of ferritin have emphasized the fact that the spatial organization of ferritin can affect the apparent R 2 . One way to modulate the relaxivity of a superparamagnetic molecule is to allow it to aggregate (25) (26) (27) (30) (31) . Indeed, controlling the aggregation of superparamagnetic contrast agents has been proposed as a way to make functional MRI contrast agents (28, (35) (36) (37) . The goal of the present work is to determine whether the relaxivity of ferritin could be manipulated by controlled aggregation, and to measure the conditions required to optimize aggregation to modulate R 2 . We developed a computational model of ferritin in aggregation states of varying size and spacing. The results indicate that ferritin molecules in aggregates are optimally spaced at about 100 nm for peak R 2 relaxivity. To verify the findings of the model, we chemically cross-linked ferritin at close distance in vitro to study the change in R 2 .
Furthermore, we demonstrate in vitro a way to achieve spacing on the order of 100 nm by allowing ferritin to bind to a biological structure that polymerizes and depolymerizes at the correct distance. Actin, which is known to polymerize and change its structure with changes in the intra-cellular and extra-cellular environment (29) (30) , represents a large fraction (~5%) of the total cellular expressed protein, and may thus be an appropriate scaffold to bind to ferritin to create optimal spacings. Actin is a monomer which hydrolyzes ATP to form filamentous polymers in vivo. Actin is ubiquitous in mammalian cells, and forms the cytoskeletal scaffold with which the nucleus, membrane, and organelles interact. The actin cytoskeleton interacts with cell surface receptors to allow for cytokine-mediated cell motility.We examined whether ferritin cross-linked to actin in vitro could be used to space ferritin at large distances and affect R 2 . The results indicate that ferritin relaxivity can be modulated by polymerization of actin. This opens up the possibility of creating a ferritin-actin binding protein fusion that can report on the functional state of actin in cells.
Materials and Methods

Theoretical Simulations
A computational model was created (Microsoft Visual C++) to predict the MRI signal amplitude arising from water in a solution containing either disperse or aggregated perturbers. The overall scheme of the simulation was similar to that developed by Weisskoff et al (24) to study the effects of microscopic spherical perturbers on MRI relaxation. In this work, we looked at the effects of sub-micron perturber geometries and clustering on the MRI signal. Additionally, we developed a simulation of a Carr-Purcell Meiboom-Gill (CPMG) MRI pulse sequence, using a fixed diffusion time.
Spherical dipole perturbers were distributed randomly inside a simulated voxel volume with 10 µm in each of three dimensions. The perturber concentration was 6.1 nM (corresponding to a ferritin subunit concentration of about 145 nM) , and the perturbers were not allowed to overlap. Each perturber was given a surface field offset of 20 G. An 11.7T magnetic field was assumed. A water molecule, assumed to be infinitely small, was then placed within a smaller volume (100 nm isotropic) inside the center of the simulated voxel, and was allowed to diffuse through the 10µm 3 isotropic voxel. To simulate the effects of perturber aggregation on the MR signal, a single perturber was placed at a random location, and then a specified number of perturbers were placed at fixed locations around it to form a cube. The spacing between individual perturbers was varied, as was the number of perturbers in each of the clusters, but the total number of perturbers in the simulated volume was held constant.
To simulate a multiple-echo (CPMG) experiment, an echo-time (TE) was specified, and the water underwent a three-dimensional random walk through the field of perturbers during TE at a rate of 10,000 steps per second. Before each step, a random angle between each of three axes was computed to determine the direction of the next step, and water was not allowed to penetrate the perturbers. The effective diffusion coefficient based on empirical calculation of the RMS diffusion distance of water over TE was 4.24x10 -4 mm 2 /sec, or about 1/5 the diffusion coefficient of free water. After each step, the magnetic field at the location of the water molecule was calculated by adding the field contributions from every perturber at the location of the water. The phase was reversed five times to simulate five echoes, and signal intensity was calculated between each echo. We note that this would simulate an instantaneous 180 o pulse, which is impossible in experiment. The perturbers were redistributed before each water molecule was placed in the field to randomize the spatial distribution of the perturbers. The total phase of the water molecule, which was the accumulated sum of the frequencies during the whole TE, was stored. This process was repeated for a total of 10,000 water molecules with a varying number of perturbers. The measurements of signal intensity with these parameters were accurate to less than 1%, as long as the normalized signal intensity was greater than 0.1. The measurements were all made in this range.
Chemical Cross-linking of Ferritin
To establish whether short-distance aggregation of ferritin could increase per-iron relaxivity in vitro, we created ferritin aggregates that were cross-linked at short distance. Iron concentrations of all stock ferritin samples used in this work were obtained from West Coast Analytical Service, Inc., Santa Fe Springs, CA. Cationized horse spleen ferritin (CF), a polycationic derivative of horse spleen ferritin, was obtained from Sigma (St. Louis, MO). To construct CF, the carboxyl groups of ferritin were activated by the manufacturer with a water-soluble carbodiimide and then reacted with N,N dimethyl-1,3 propanediamine (DMPA) to introduce free amine groups to the CF (34) . Based on the electrometric titration of CF by Danon et al. (34) , CF contains approximately 80-100 added free amine groups per ferritin cage.
We used 3,3'-dithiobis(sulfosuccinimidylpropionate) (DTSSP, Pierce, Rockford, IL) to crosslinked CF. DTSSP is a soluble succinimidyl ester containing a disulfide bond linking binding sites to two free amines. DTSSP forms a 12 Å (0.1 nm) spacer between neighboring cross-linked proteins. The structure of DTSSP is shown in Fig. 1a , with binding sites for the ferritin subunits shown in arrows.
The DTSSP cross-linking reaction was performed in phosphate-buffered saline (PBS), and 2-amino-2-hydroxymethyl-1,3-propanediol (TRIS) competitively inhibited the reaction. In addition, crosslinking with DTSSP was reversed using dithiothreitol (DTT), which reduces (cleaves) the di-sulfide bond between the the DTSSP cross-linkers. Before use, DTSSP was mixed with PBS at a 10 mg/ml concentration and put into solution by vigorous vortexing.
The experimental design for the ferritin aggregation experiments is shown in Fig. 1b . In crosslinked and control experiments respectively, CF was mixed with 0.9 ml PBS, or 0.9 ml TRIS buffer (PH 7.4, 1M) in concentrations from 50 nM to 500 nM (CF cage polymers). In both cross-linked and control samples, the DTSSP-PBS solution was added and thoroughly mixed by pipetting. After one hour, 0.9 ml of TRIS was mixed by pipette with the cross-linked samples, and 0.9 ml of PBS was mixed with the control samples, making the total volumes (and ferritin, TRIS, and PBS concentrations) of the crosslinked and control samples the same. Any differences in the MR properties between cross-linked and control samples should thus be only due to the time allowed for aggregation to occur before the TRIS was added. The samples were then mixed 1:1 with 2% molten low-melting point (LMP) agarose (SEAChem, Madison, GA.), at approximately 40 o C, in glass test tubes and allowed to cool for one hour at room temperature before imaging. To determine whether reversal of cross-linking could reverse any change in R 2 with aggregation, we added 50 µl of 10 mg/ml DTT to 900 µl of the cross-linked and 900 ul of the control samples. The experiments were repeated three times using separate cross-linked and control samples. The aggregate size distribution for the conditions of these experiments was determined by electron microscopy (described below).
Actin-Ferritin Conjugation and Actin Polymerization
As described in the Results section, the computer simulations predicted a dependence of ferritin relaxivity on the spacing between individual ferritins in the aggregate. To explore this effect in vitro, and to make a biologically relevant construct of aggregated ferritin, we attached ferritin to actin and allowed actin polymerization to determine the spacing of the ferritin molecules.
Biotinylated rabbit skeletal muscle actin, and all actin buffer solutions were purchased from Cytoskeleton, Inc. (Denver, CO). Avidin-ferritin, composed of horse-spleen ferritin conjugated to avidin (EY Labs, San Mateo, CA), was used. We added 2 µl of dH 2 O and 48 µl of general actin buffer (5mM Tris , 0.2 mM CaCl 2 , 0.2 mM ATP) to 2 µg of dehydrated biotin-actin and incubated for one hour at room temperature.
To determine whether actin-ferritin could polymerize, 100 µl of avidin-ferritin (5 mg/ml) or general actin buffer were added to 20 µl of the biotin-actin solution and the samples were incubated 30 minutes at room temperature. We added 12 µl of polymerization buffer (500 mM KCl, 20mM MgCl 2 and 10 mM ATP) one hour prior to or directly before suspension in 2% molten agarose in dH 2 O (Bioline Inc., Randolph, MA) for TEM, or left in solution for MRI. The concentration of ferritin cages was 3.5 µM. Hereafter, g-actin (globular actin) refers to unpolymerized actin, and f-actin refers to actin incubated with polymerization buffer for one hour.
To modulate R 2 by modifying the spacing between each of the ferritin molecules, we mixed biotinactin with rhodamine-actin in proportions of 1:1.5 and 1:5, then allowed the avidin-ferritin to conjugate with the mixture before polymerization (as above). This should allow only some of the ferritin to be attached to f-actin, which should increase the overall distance between the ferritin cages. The samples were observed under EM (see below, with samples prepared by adsorption to the carbon grid).
Fluorescence Microscopy
Actin, both ferritin-conjugated and by itself in g-and f-forms, was incubated with a rhodaminephalloidin (Cytoskeleton, Denver, CO) conjugate for fluorescence microscopy. Fluorescence microscopy was performed using a Leica MZ FLIII stereo microscope with a TRITC/DiI filter (excitation 540 nm, emission 605 nm, Chroma Technology Corp, Rockingham, VT). For imaging, 10 µl of the actin sample were dropped onto a microscope slide and covered with a coverslip.
Electron Microscopy
All images were taken with a Jeol (Peabody, MA) JEM-200CX electron microscope. For embedded samples of cross-linked and actin-conjugated ferritin sample, the samples were mixed with 10% agarose. Cacodylate buffer was added to the sample in a test tube and stored at 4 o C. Selected areas were trimmed, dehydrated with a graded series of ethanol mixtures, infiltrated with graded mixtures of ethanol and epoxy resin (SPI Supplies; West Chester, PA), and embedded in epoxy resin. Polymerization of the resin was carried out at 60 o C for at least 48 hours. For carbon-grid adsorption, samples were adsorbed onto 400 heaxagonal mesh thin bar Cu Grids (EMS; Fort Washington, PA) coated with 1% formvar in ethylene dichloride (EMS) by settling for 5 minutes, blotting and drying for 15 minutes. Separate grid-adsorbed samples were then negatively stained with 0, 0.25%, and 0.5% uranyl acetate in water.
Two different preparations of actin-ferritin were prepared for the cross-linked and control conditions. In the first, cross-linked and control samples were mixed 1:1 with 10% LMP agar and allowed to cool. In one of the samples, containing no ferritin, 0.5% uranyl acetate in 0.1M acetate buffer was added to the section to provide negative contrast and enable visualization of the actin filaments. Experiments were repeated three times with similar results.
Ferritin was easily identified with no negative staining, and appeared to be arranged in filaments. Additionally, f-actin filaments were identified with uranyl acetate staining, but it was difficult to obtain sufficient contrast to identify actin and ferritin together due to absorption of uranyl acetate by the agar. The samples were therefore adsorbed onto carbon grids, as described above.
Magnetic Resonance Imaging
Samples of the chemically cross-linked ferritin in agar were imaged in 1.5 ml Eppendorf or 200 µl tubes and placed in a 35 mm ID Bruker transmit/receive probe in a Bruker 11.7T scanner with a 31 cm bore. For T 2 mapping, a multi-shot multi-echo pulse sequence was used (TE/TR = 6/3000 ms). Five slices of 0.5 mm slice thickness were acquired, with 0.5 mm between each slice. In-plane resolution was 200×200 µm using a 128 x 128 matrix with a 25.6 mm square field-of-view.
Actin was imaged in solution. We used a custom-built 55 mm ID transmit/receiver RF coil that allowed the samples to remain upright. All imaging parameters were the same as with the chemically cross-linked samples.
Results
Simulations
In simulations of the MRI signal intensity in a single voxel, ferritin-sized perturbers were randomly distributed in the pixel. The perturbers were allowed to aggregate with 2, 3, 4, or 5 perturbers in each dimension with no spacing between the perturbers. The space between the edges of the perturbers was also varied from 50 nm to 500 nm, and the MRI signal intensity was compared between the perturber orientations. Figure 2a shows a typical plot of the simulated MRI signal intensity (on a negative log scale) as a function of TE, at each echo, for a zero-distance perturber spacing, with the number of perturbers in the aggregate varied from 8 (2×2×2 perturbers ) to 125 (5×5×5 perturbers). Relaxivity was estimated by the slope of each curve. Figure 2b shows the resulting change in R 2 compared to the case of close-packed, (0 nm), aggregate of the same number of perturbers. Figure 2c shows the same data, compared to the case of randomly distributed ferritins. The simulation shows that increasing the distance between ferritins in varying size aggregates can cause an increase in R 2 by up to 60% as compared to an aggregate with no space between ferritins. In comparison to randomly distributed ferritin, aggregation can either increase or decrease R 2 depending on the ferritin spacing. This effect is assumed to arise from the transition of the relaxivity between static-dephasing and diffusion-limited regimes when ferritin spacing is modulated (24) . The peak relaxivity in this case occurred with 64 perturbers, corresponding to a perturber diameter of approximately 500 nm. The greatest gain in R 2 was achieved when aggregate size was modulated in the range of 50-100 perturbers.
We examined whether the sensitivity to aggregate size was due to the fact that, when more ferritins are in an aggregate, a water molecule may not experience the magnetic field of the cluster at all during the random walk. We therefore compared the magnetic field offsets at the locations of several water molecules during the walk. All water molecules were found to experience at least one magnetic field offset due to the perturbers during the random walk (data not shown).
Chemical Cross-linking of Ferritin
Ferritin aggregates were observed in cross-linked samples using TEM with no negative staining. The spatial distribution of grid-adsorbed normal and aggregated ferritin is shown in Fig 3a and Fig 3b, respectively. The distance across the large aggregates was measured to be about 150 nm on average, measured by the longest axis across embedded aggregates. The distribution of aggregate sizes is shown in Fig. 3c , for aggregated and native ferritin.
The MRI signal intensity in cross-linked and control samples decreased with increasing ferritin concentration. Typical MR images are shown in Fig. 4a , with increasing concentrations of ferritin. The sample of aggregated ferritin was visibly darkened in T2-weighted images (TE = 36 ms) compared to controls. R 2 values, determined by fitting the signal decay with a mono-exponential function, were used to compute relaxivity (per iron). The computed R 2 values are seen in Fig. 4b , corresponding to the ferritin concentrations used in the samples of Fig. 4a . The values of R 2 relaxivity, obtained by linear regression of the curves of Fig. 4b ,are shown in Fig. 4c . Cross-linking of ferritin increased R 2 relaxivity by approximately 70%, which was statistically significant ( p < 0.05, t-test). The addition of DTT to reduce the disulfide linker caused relaxivity to decrease to the level of the control.
From these results, we concluded that chemical cross-linking of ferritin at short distance can increase R 2 relaxivity. This leads to a decrease in MRI signal intensity which is detectable at reasonable echo-times (10-40 ms) at high field strength. Additionally, the effect of cross-linking on R 2 relaxivity can be reversed by cleavage of the cross-linker.
Actin-Ferritin Conjugation and Actin Polymerization
In order to increase ferritin spacing to distances approaching 100 nm, we used polymerized actin as a scaffold for ferritin binding. The polymerization of actin in vitro was confirmed by fluorescence microscopy using rhodamine-phalloidin. No structured fluorescence was observed with G-actin samples (Fig. 5a ), while filaments of f-actin were seen (Fig. 5b) . The size of the filaments was on the order of 10-100 µm in length. G-and f-actin conjugates of ferritin were visible in TEM after adsorption to the carbon grid (Figs 5c and 5d) , confirming that f-actin could still polymerize when ferritin was attached. F-actin was also visible in TEM of agarose-embedded sample. Uranyl acetate staining provided excellent contrast of unpolymerized ferritin-actin and polymerized actin filaments in the agar (Fig. 5e-f) . The iron cores of individual ferritin molecules attached to polymerized actin were visible in TEM with no counterstain in agar blocks (Fig. 5f ). In this experiment, the close spacing of the individual ferritins was expected because the ferritin concentration was equal to the actin concentration, and the ferritin molecules were separated by approximately 5 nm. Filaments were approximately 200 nm in length and 5-10 nm in width. No filaments were observed in the g-actin sample, but there was some aggregation of ferritin-g-actin in gridadsorbed samples, as seen in Fig. 5c .
To determine whether an increased space between ferritin molecules in the aggregates could be used to modulate R 2 , we used a 1:1.5 or 1:5 ratio of biotin actin to non-biotin (rhodamine-) actin in the samples. Fig. 6a shows TEM images of these samples at two different magnifications. At constant ferritin concentrations, the spacing between ferritin iron cores in and around the aggregates increased from approximately 10 nm to 20-60 nm. There were more ferritins outside of the aggregates in the sample with a 1:5 ratio of biotin to non-biotin actin, and there was a heterogenous distribution of spacing and aggregate sizes within the sample. Figure 6b shows the value of R 2 for g-and f-actin, and for different concentrations of biotinylated actin, as obtained by fitting the signal attenuation curves for each sample. R 2 increased by approximately 23% with actin polymerization, and the difference was significant (p<0.05). The value of R 2 was also significantly higher between the 1:1.5 samples and the 1:5 samples of g-actin
We concluded that ferritin can be conjugated to actin in vitro, and that the ferritin-actin conjugates are observable under electron microscopy. The polymerization of ferritin-conjugated actin can be detected with MRI by its effect on R 2 , and this effect can be modulated by changing the space between ferritins.
Discussion
In this work, we studied how the aggregation of ferritin can affect R 2 in MRI measurments. Aggregation is known to affect the relaxivities of superparamagnetic particles (24) (25) 29) , and here we calculated the effects of size and inter-particle spacing on the relaxivity of a model for ferritin. To the best of our knowledge this is the first time the effects of inter-particle spacing have been examined.
We used a computational model to study the change in relaxation rates for a number of perturber cluster sizes and inter-perturber spacings in spin-echo experiments. Qualitatively, the change in relaxation rates with perturber cluster size were in agreement with Weisskoff et al. (24) when the perturbers were touching. R 2 increased with cluster size, indicating that relaxation was diffusion limited at these perturber sizes. When the space between perturbers in the aggregates was increased, the maximum R 2 also increased. Based on the simulated results, a perturber spacing of 100-250 nm resulted in the largest ∆R 2 . The optimal aggregate size was approximately 60-100 perturbers. To control for the effect of variations in the iron loading factor in ferritin on the maximum ∆R 2 , we also simulated the case where the surface field offset was an order of magnitude greater (data not shown). Although the maximum ∆R 2 could be modulated in this way, the perturber sizes and spacing to achieve maximum ∆R 2 were approximately the same. While the simulations are for superparamagnetic clusters, they are relevant for paramagnetic clusters and may explain the large relaxation detected in nanostructures such as gadolinium doped carbon nanostructures (39) . This work demonstrates that it is feasible to rationally modify the distance between ferritin in a synthetic or endogenous contrast agent to modulate relaxivity, consistent with previous work with dextran coated iron oxide particles (34, (36) (37) (38) .
To experimentally verify the trends predicted by the model, ferritin was crosslinked at short distances and bound to actin to cluster at larger distances. Crosslinking ferritin at short spacing increased R 2 by 70% from 9mM -1 s -1 to 16mM -1 s -1 . The value of of 9 mM -1 s -1 for unaggregated ferritin is within the range previously reported (12) . There was an increase in R 2 by 30% by binding ferritin to actin and increasing the ferritin spacing to ~ 50 nm.
Considering that the magnetic field offset from B 0 decreases as the cube of distance from the center of a perturber, it follows that the magnetic field 6.5 nm (2 × r) from a ferritin molecule is 12.5% of the value at the surface. At 19.5 nm (3 × r) away, the field offset drops to 3.7%. With three-dimensionally symmetric aggregation, the gradient is less steep. For instance, if the radius of the aggregation sphere is twice that of the single ferritin, the magnetic field offset is 67% at 6.5 nm, and 40% at 19.5 nm. Thus, as the aggregate size increases, (assuming a zero-length spacer), the field perturbation is accessible to more of the water, but the size of the perturbing field gradient is reduced. Since the magnetic field gradient is responsible for dephasing, the goal in improving relaxivity via aggregation is to ensure that water is exposed to the field gradient as often as possible during the experiment. Both the effect of aggregating at short distance and altering inter-particle spacing within aggregates can change R 2 . The complexity of all of the factors involved makes it necessary to perform simulations as we have here to help optimize their effects.
Inner sphere effects are known to affect the T 2 relaxivity of ferritin (20) . It is thought that water adsorbed to the surface of the ferritin core is in rapid exchange with the bulk water, which adds to the intrinsic T 2 of ferritin in solution. However, aggregation of ferritin is not expected to decrease exchange of protons at the surface with the bulk water. Additionally, as noted above, the long-range magnetic field gradient induced at the core surface from a neighboring ferritin core, even when aggregated, is much smaller than at the surface. The effects of aggregation on relaxation are thus thought to arise from outer sphere mechanisms.
An alternative explanation for the relaxivity change with ferritin aggregation is that water becomes trapped between ferritins inside the aggregates. Trapped water would substantially increase the phase accumulation of water in the aggregates by forcing them to be in the vicinity of the dipolar fields of the ferritin molecules. In the simulations, this effect seems unlikely because, even with the largest aggregates, the volume of the aggregate only comprises approximately 0.3% of the total volume of the simulated voxel. In experiments with actin-ferritin conjugates, this effect seems unlikely in the bulk water, because the polymerized actin structure should prevent water from becoming trapped in the middle of the ferritin clusters. There is a possibility that water bound to the surface of actin is experiencing a large dephasing magnetic field. The case of g-actin most likely represents close-packed ferritin in small clusters, which explains why R 2 increased rather than decreased with polymerization in these experiments.
The effects of ferritin aggregation and spacing on relaxivity depend upon the diffusion coefficient of the water, time allowed during the experiment for diffusion through the gradients to occur (inter-echo spacing), and the distance between the perturbers in the aggregates. Additionally, the amount of iron loading in the ferritin determines the total signal available at a specific TE, and the distance the magnetic field gradient extends from each molecule. In the simulations presented here, water diffused approximately 3 µm during the experiment. This compares to a perturber aggregate diameter range of 65 nm to 1.27 µm in the largest aggregates (5 x 5 x 5). The peak relaxivity change occurred when this aggregate was 600 nm across. For smaller aggregates, the diameter of the aggregate for peak relaxivity was smaller (approximately 125 nm with the 2x2x2 perturbers). We hypothesize that this represents an interplay between two effects: 1. Maximum relaxation for very sparse perturbers, with diffusion distance less than the inter-perturber distance, occurs when the perturber size is largest. This is seen with the largest aggregates, where the water experiences few perturbers but a very large gradient when it is in the vicinity of the aggregates. 2. When perturbers are less sparse, the water experiences a smaller gradient more often during the experiment, as happens when the aggregates are smaller. As the diffusion coefficient increases, there is expected to be less difference between these two cases. In general, the complicated nature of aggregation suggests that it is appropriate to design a biological construct that is tailored to the microenvironment of the cellular water and the loading factor of ferritin.
An aim of this work was to determine optimal conditions for aggregation of ferritin to improve R 2 relaxivity for MRI. It is instructive to consider whether or not these small changes in R 2 by ferritin concentration and polymerization status could potentially be detected in vivo. If one assumes some arbitrary threshold for detection of ∆R 2 by ferritin expression, aggregation of the ferritin will thus allow detection at a lower concentration. It is still unclear exactly what this threshold is. We estimate that, for a 10% change in signal intensity, given an R 2 relaxivity of 10 mM -1 /sec, about a 200 µM ferritin subunit (5 µM cages) concentration is required. Based on the work presented here, perhaps a 100 µM ferritin subunit (2.5 µM cages) concentration could be detected if the ferritin were engineered to aggregate. At this concentration, every ferritin cage would be spaced about 70 nm apart (center-to-center) if uniformly distributed in the entire imaging voxel, demonstrating the high levels of ferritin expression required to be detectable by MRI. However, it is known that ferritin aggregation occurs to some degree in vivo in the form of hemosiderin (21) (22) which would decrease the effect that engineering ferritin aggregates would have.
An alternate and perhaps more interesting implication of this work is that allowing ferritin to alter spacing in a cell can enable reporting on the functional state of different structures. For instance, actin structure is known to change with rapid changes in cellular ion concentrations (29) (30) (31) (32) , during cell cycle transitions, and during cell migration. Producing a ferritin-actin form by ferritin-actin fusion, or by fusion of ferritin to an actin binding protein, could be used to change spacing between ferritin and to detect actin polymerization states that change on the order of minutes to hours. Other cellular phenomena, such as cell signaling and apoptosis, could potentially be detected by coupling the aggregation of ferritin to proteins that aggregate upon activation. Previous work has proposed controlling the aggregation of iron oxide particles at short distances to make functional MRI contrast agents that report on membrane potentials, enzyme activity or Ca 2+ levels (30, (37) (38) (39) . It is not clear as yet how to efficiently deliver these agents to cells, nor whether the relatively large particles will be able to diffuse through the cell on relevant time scales. Engineering particles to change spacing at relatively short distances (~ 50 nm) may offer many advantages for making the aggregation of super-paramagnetic particles a practical strategy for generating functional MRI contrast. Actin is expressed at approximately 1.5 mg/ml (41) in the cytosol, or at a concentration of approximately 350 µM. On average, this would require approximately 3.5 x 10 7 actin monomers in a volume of 1 pl, corresponding to the volume of a cell of 10 µm 3 . This would suggest there are 1.5 g-actin monomers per nm, and that an actin-ferritin fusion must be expressed at a concentration of 10 µM to be spaced at a distance of 50 nm if actin-ferritin is completely dispersed in the cell.
In this work, we have shown how ferritin aggregation can change transverse MR relaxivity. A computational model was developed to determine how the spacing and size of these aggregates affects ∆R 2 . The model demonstrates that inter-particle spacing within an aggregate on the order of 100 nm modulates R 2 . We chemically cross-linked ferritin cages in-vitro, at short distance, and found that relaxivity was increased by about 70% with ferritin aggregates of about 100 microns isotropically. We also conjugated ferritin to actin, which was then polymerized to increase R 2 relaxivity by 30%. We hypothesize that the controlled in vivo aggregation of ferritin can be achieved to improve the detectability of gene expression in mammalian cells, and binding ferritin to cellular micro-structures such as the actin cytoskeleton may be a way to generate MRI contrast from changes in cell function. 
